Research Progress on 18F-Labeled Agents for Imaging of Myocardial Perfusion with Positron Emission Tomography

Tiantian Mou1, Xianzhong Zhang2

  • 1Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China. mtt207@163.com.

Insights

Fluorine-18 labeled myocardial perfusion imaging (MPI) tracers show promise for diagnosing coronary artery disease (CAD). This review covers current research and future directions for these vital diagnostic tools.

Area of Science:

  • Nuclear medicine
  • Radiochemistry
  • Cardiology

Background:

  • Coronary artery disease (CAD) remains a leading global cause of mortality.
  • Myocardial perfusion imaging (MPI) is crucial for non-invasive CAD diagnosis and prognosis.
  • Current MPI agents have limitations in meeting clinical demands.

Purpose of the Study:

  • To review the advancements in 18F-labeled MPI tracers.
  • To summarize the basic research data of these tracers.
  • To outline future research directions in MPI tracer development.

Main Methods:

  • Literature review of 18F-labeled MPI tracers.
  • Analysis of basic research data for selected tracers.
  • Discussion of clinical applications and future potential.

Main Results:

  • Significant progress has been made in developing 18F-labeled MPI tracers.
  • Various 18F-labeled tracers exhibit promising characteristics for myocardial perfusion assessment.
  • The review consolidates current knowledge on tracer performance and development.

Conclusions:

  • 18F-labeled tracers represent a significant advancement in MPI for CAD.
  • Further research is needed to optimize existing tracers and develop novel ones.
  • These tracers hold great potential for improving the diagnosis and management of CAD.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET